poisar

Stock

Xilio Therapeutics, Inc. XLO

$9.05+0.11%

Overview

XLO market data

Price History

XLO price chart · 3M
O
9.05
H
9.05
L
9.05
C
9.05
Vol
111.00
Source
US equities market feed
Observed
Cadence
Five-minute page cache; daily and stored hourly bars
Status
fresh

Key Stats & Performance

Open
$9.05
Previous Close
$9.04
Day High
$9.05
Day Low
$9.05
52 Week High
$9.75
52 Week Low
$7.61
7 Day Return
+0.33%
30 Day Return
-1.42%
90 Day Return
+16.32%
1 Year Return
+15.73%
Daily Notional Volume
$1K
Latest daily bar volume multiplied by its closing price.

Valuation & Profitability

Provider-backed
P/E (TTM)
Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
Forward P/E
P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
EPS (TTM)
-$4.19
Diluted earnings per share over the trailing twelve months.
Beta
-0.11
Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
Dividend Yield
Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
Profit Margin
-34.1%
Net income divided by revenue. Comparable within a sector, less so across sectors.
52w range
$6.47 – $12.74
Lowest and highest closing prices over the past 52 weeks.
Analyst Target
Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.

Display-only. Refreshed once per symbol per 24 hours · market cap $59.2M · P/B 0.95 · P/S 0.92.

Company News

3 captured

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock
Xilio Therapeutics, Inc. (XLO) stock — price history, valuation & news | Poisar